Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

China · Delayed Price · Currency is CNY

17.96

+1.63 (9.98%)

Jun 18, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Chinese Patent Medicine	28.26M	-	-	-	-
Chemical Medicine	1.84M	-	-	-	-
Active Pharmaceutical Ingredient (API)	30.30M	-	-	-	-
Health Care Products	90.99M	-	-	-	-
Circulating Commodities	50.35M	-	-	-	-
Medical Instruments	3.79M	-	-	-	-
Service Type	5.19M	-	-	-	-
Other	979.71K	-	-	-	-
Total	211.70M	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	211.75M	217.30M	121.78M	108.91M	147.07M
China Growth	-2.55%	78.44%	11.82%	-25.95%	-28.82%
Total	211.75M	217.30M	121.78M	108.91M	147.07M
Total Growth	-2.55%	78.44%	11.82%	-25.95%	-28.82%